Literature DB >> 31255203

Evaluation and Management of Primary Hyperaldosteronism.

Frances T Lee1, Dina Elaraj2.   

Abstract

Primary hyperaldosteronism is an important and increasingly prevalent cause of hypertension that is characterized by unregulated aldosterone excess. More than 90% of primary hyperaldosteronism cases are attributable to either idiopathic adrenal hyperplasia or aldosterone-producing adenomas. The approach to the diagnosis of primary hyperaldosteronism should be step-wise, starting with screening of at-risk populations, confirmatory testing for positively screened patients, and subtype classification in order to direct surgical or medical management. Based on current guidelines, subtype classification of primary hyperaldosteronism should be determined with both imaging and adrenal vein sampling (AVS), reserving deferment of AVS for a selective subset of patients.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenoma; Adrenal hyperplasia; Aldosterone excess; Hyperaldosteronism; Primary hyperaldosteronism

Mesh:

Year:  2019        PMID: 31255203     DOI: 10.1016/j.suc.2019.04.010

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

1.  Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism.

Authors:  Shivraj Grewal; Andin Fosam; Liam Chalk; Arjun Deven; Mari Suzuki; Ricardo Rafael Correa; Jenny E Blau; Andrew Paul Demidowich; Constantine A Stratakis; Ranganath Muniyappa
Journal:  Endocrine       Date:  2021-01-18       Impact factor: 3.633

2.  Seizure and coma secondary to Conn's syndrome: a case report.

Authors:  Eiman Alseddeeqi; Ajda Altinoz; Najla Ben Ghashir
Journal:  J Med Case Rep       Date:  2020-07-15

3.  A Rare Aldosterone-Producing Adenoma Detected by 68Ga-pentixafor PET-CT: A Case Report and Literature Review.

Authors:  Yunying Cui; Yushi Zhang; Jie Ding; Huiping Wang; Xiaoshen Ma; Ou Wang; Xiaoyan Chang; Hao Sun; Li Huo; Anli Tong
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-29       Impact factor: 5.555

4.  Consensus paper on the evaluation and treatment of resistant hypertension by the Turkish Society of Cardiology.

Authors:  Asife Sahinarslan; Emine Gazi; Meryem Aktoz; Cigdem Ozkan; Gülay Ulusal Okyay; Ozgul Ucar Elalmis; Erdal Belen; Reviewers Atila Bitigen; Ulver Derici; Neslihan Bascil Tutuncu; Aylin Yildirir
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596

5.  Thirty-six-month results of laparoscopic-based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone-producing adenoma.

Authors:  Yahui Liu; Binbin Zhu; Lijie Zhu; Linwei Zhao; Zhiqiang Fan; Degang Ding; Zhonghua Liu; Qiuping Zhao; Datun Qi; You Zhang; Ji-Guang Wang; Chuanyu Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-16       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.